Oxandrolone and Proviron Interaction

Avoid
Mechanism-based 64% confidence

Oxandrolone and Proviron have a potentially harmful interaction with 64% confidence. Both Oxandrolone and Proviron carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. Both compounds affect the gonads and liver and heart, so monitoring these systems is recommended.

Compound Profiles

Oxandrolone

Oral Anabolic Steroid | Lean Mass & Recovery

Oxandrolone exerts its anabolic effects primarily through binding to the intracellular androgen receptor (AR), promoting nitrogen retention and protein synthesis in skeletal muscle tissue. As a DHT derivative, it cannot be converted to estrogen by the aromatase enzyme, which means it does not cause estrogen-mediated water retention or gynecomastia.

Half-life: ~9-10 hours Typical dose: 20-50 mg/day (male), 5-20 mg/day (female) anabolic, healing
5 alpha reductaseandrogen receptoraromataseshbg androgeniccarcinogenic riskhepatotoxichpta suppressive
View full profile

Proviron

DHT Derivative | Mood, Libido & Muscle Hardening

Proviron exerts its effects primarily through direct binding to the androgen receptor (AR) as a potent DHT analogue. However, its most therapeutically relevant mechanism is its exceptionally high binding affinity for sex hormone-binding globulin (SHBG).

Half-life: ~12 hours Typical dose: 25-75 mg/day anabolic, sexual health
androgen receptoraromataseepo receptorshbg androgenicaromatase inhibitorcarcinogenic riskhepatotoxic
View full profile

Combined Organ Load

Gonads
elevated
Liver
elevated
Heart
moderate
Blood Vessels
low

Shared Safety Flags

2x 2 androgenic compounds (Oxandrolone, Proviron). Additive androgenic load — increased risk of hair loss, acne, prostate effects.
2x 2 compounds share the carcinogenic-risk safety flag (Oxandrolone, Proviron). Monitor accordingly.
2x 2 hepatotoxic compounds (Oxandrolone, Proviron). Liver damage risk significantly increased. Include liver support (TUDCA/NAC) and monitor ALT/AST.
2x 2 HPTA-suppressive compounds (Oxandrolone, Proviron). Deep hormonal shutdown expected — plan extended PCT.
2x 2 compounds disrupt lipids (Oxandrolone, Proviron). Get lipid panel mid-cycle — consider adding lipid support.
2x 2 compounds share the teratogenic safety flag (Oxandrolone, Proviron). Monitor accordingly.

Frequently Asked Questions

Can I take Oxandrolone with Proviron?

Combining Oxandrolone with Proviron is not recommended. Both Oxandrolone and Proviron carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently.

Is Oxandrolone and Proviron safe together?

This combination carries significant risk. Both Oxandrolone and Proviron carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. Consult a healthcare professional before combining.

What are the interactions between Oxandrolone and Proviron?

Both Oxandrolone and Proviron carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. This assessment has 64% confidence and is inferred from pharmacological mechanism analysis.

How should I time Oxandrolone and Proviron?

Oxandrolone has a half-life of ~9-10 hours and Proviron has a half-life of ~12 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Oxandrolone vs Proviron

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.